|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 31/5375 | |
| A61P 25/00 | |||
| A61P 25/24 |
| (11) | Number of the document | 2341912 |
| (13) | Kind of document | T |
| (96) | European patent application number | 09812256.7 |
| Date of filing the European patent application | 2009-09-04 | |
| (97) | Date of publication of the European application | 2011-07-13 |
| (45) | Date of publication and mention of the grant of the patent | 2014-01-22 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2009/055980 |
| Date | 2009-09-04 |
| (87) | Number | WO 2010/028207 |
| Date | 2010-03-11 |
| (30) | Number | Date | Country code |
| 94502 P | 2008-09-05 | US |
| (72) |
BREDER, Christopher, D., US
|
| (73) |
Supernus Pharmaceuticals, Inc.,
1550 East Gude Drive, Rockville, MD 20850,
US
|
| (54) | METHOD OF TREATMENT OF ATTENTION DEFICIT/HYPERACTIVITY DISORDER (ADHD) |
| METHOD OF TREATMENT OF ATTENTION DEFICIT/HYPERACTIVITY DISORDER (ADHD) |